ALK and mature T-cell and NK-cell non-Hodgkin lymphoma: Although most patients with systemic ALK-negative ALCL present with stage III and IV disease and associated B symptoms, the prognosis is better than that of PTCL-NOS using conventional chemotherapy [22].